Lillyporkgames.US) fell 3% to 733porkgames.27 dollars. on the news frontporkgamesMid-term trial of Amgen's new weight-loss drug gets positive dataporkgamesIf the drug is approved, it will compete with Novo Nordisk's Wegovy and Lilly's Zepbound.
Earlier, some media said that Amgen is trying a new weight-loss drug, whose mechanism of action is different from Novo Nordisk and Lilly products, which can prevent patients from gaining weight even if they stop taking the drug.
Comments